Found 785 bookmarks
Newest
Opinion: A role for placebo therapy in psychogenic movement disorders - PubMed
Opinion: A role for placebo therapy in psychogenic movement disorders - PubMed
Psychogenic movement disorders (PMDs) mimic known movement disorders but are not attributed to an underlying neurological pathology and are generally thought to have a psychological origin. Owing to the lack of a clear pathology, patients often experience multiple referrals, frequent office visits, …
·pubmed.ncbi.nlm.nih.gov·
Opinion: A role for placebo therapy in psychogenic movement disorders - PubMed
Placebo response in anxiety disorders - PubMed
Placebo response in anxiety disorders - PubMed
Examination of the literature suggests that placebo response rates in studies of anxiolytics are influences by a number of factors, including both endogenous and exogenous variables. High placebo response rates may mask true drug response rates and may result from poor study design or lack of proced …
·pubmed.ncbi.nlm.nih.gov·
Placebo response in anxiety disorders - PubMed
Placebo Responses Among Men With Erectile Dysfunction Enrolled in Phosphodiesterase 5 Inhibitor Trials: A Systematic Review and Meta-analysis - PubMed
Placebo Responses Among Men With Erectile Dysfunction Enrolled in Phosphodiesterase 5 Inhibitor Trials: A Systematic Review and Meta-analysis - PubMed
In this study, placebo was associated with improvement of ED, especially among men with ED-related posttraumatic stress disorder. No difference was found between placebo and PDE5I among men treated for ED after prostate surgery.
·pubmed.ncbi.nlm.nih.gov·
Placebo Responses Among Men With Erectile Dysfunction Enrolled in Phosphodiesterase 5 Inhibitor Trials: A Systematic Review and Meta-analysis - PubMed
The placebo effect - PubMed
The placebo effect - PubMed
Placebos have been traditionally regarded as deceptive therapies and have not been understood in the broader context of social symbols and of interpersonal factors that surround the healing process itself. Although the power of inert substances to heal is well recognized, the placebo effect also inf …
·pubmed.ncbi.nlm.nih.gov·
The placebo effect - PubMed
What's in placebos: who knows? Analysis of randomized, controlled trials - PubMed
What's in placebos: who knows? Analysis of randomized, controlled trials - PubMed
Placebos were seldom described in randomized, controlled trials of pills or capsules. Because the nature of the placebo can influence trial outcomes, placebo formulation should be disclosed in reports of placebo-controlled trials.
·pubmed.ncbi.nlm.nih.gov·
What's in placebos: who knows? Analysis of randomized, controlled trials - PubMed
Expectation, the placebo effect and the response to treatment - PubMed
Expectation, the placebo effect and the response to treatment - PubMed
What we believe we will experience from a treatment--our expectation--has a substantial impact on what we actually experience. Expectation has been established as a key process behind the placebo effect. Studies in both laboratory and clinical settings consistently show that when people ingest a pha …
·pubmed.ncbi.nlm.nih.gov·
Expectation, the placebo effect and the response to treatment - PubMed
[Believe in what you practice] - PubMed
[Believe in what you practice] - PubMed
A recent meta-analysis showed that antidepressants are more effective than placebo. In placebo-controlled trials, the placebo effect is subtracted from the verum effect to find the specific effect of each antidepressant. In clinical practice, however, the situation is the other way around: non-speci …
·pubmed.ncbi.nlm.nih.gov·
[Believe in what you practice] - PubMed
Metrifonate. Summary of toxicological and pharmacological information available - PubMed
Metrifonate. Summary of toxicological and pharmacological information available - PubMed
The organophosphorus compound 0,0-dimethyl-(1-hydroxy-2,2,2-trichloroethyl)-phosphonate was introduced as an insecticide, trichlorfon, in 1952 (Lorenz et al., 1955) and as a drug, metrifonate, in the treatment of schistosomiasis in 1960 (Lebrun and Cerf, 1960). This organophosphorus compound is uniq …
·pubmed.ncbi.nlm.nih.gov·
Metrifonate. Summary of toxicological and pharmacological information available - PubMed
Prevalence of adverse drug events in ambulatory care: a systematic review - PubMed
Prevalence of adverse drug events in ambulatory care: a systematic review - PubMed
Despite a recent increase in publications on ADEs in the ambulatory care setting, most studies remain hospital based. Notable differences in prevalence rates by age groups and by responsible drug categories provide guidance on how to direct attention toward effective targets for improvement of medic …
·pubmed.ncbi.nlm.nih.gov·
Prevalence of adverse drug events in ambulatory care: a systematic review - PubMed
Resisting medicines: a synthesis of qualitative studies of medicine taking - PubMed
Resisting medicines: a synthesis of qualitative studies of medicine taking - PubMed
The study aimed to synthesise qualitative studies of lay experiences of medicine taking. Most studies focused on the experience of those not taking their medicine as prescribed, with few considering those who reject their medicines or accept them uncritically. Most were concerned with medicines for …
·pubmed.ncbi.nlm.nih.gov·
Resisting medicines: a synthesis of qualitative studies of medicine taking - PubMed
Adverse Drug Effects in Patients with CKD | American Society of Nephrology
Adverse Drug Effects in Patients with CKD | American Society of Nephrology
Medications are an indispensable cornerstone of modern health care. Clinicians prescribe drugs in the treatment of innumerable medical conditions, whereas patients and the general population self-treat various maladies with over-the-counter medications and natural and herbal products. For the most
·cjasn.asnjournals.org·
Adverse Drug Effects in Patients with CKD | American Society of Nephrology